
At the intersection of biophysics and genomics. Scribe Therapeutics @scribetx
Joined April 2013
- Tweets13
- Following106
- Followers63
- Likes82
I’ll be presenting in Scribe technology platform in two venues this week. Thanks to everyone who tunes in!
This week, tune into two events where our VP of Research Sarah Denny will break down the science and engineering approach behind our CRISPR-based genetic medicines.
1️⃣ 7th Genome Editing Therapeutics Summit hosted by the Cell & Gene Therapy Event Series, AKA #crispr2.0 (September 28-30, Boston)
2️⃣ Tech Spotlight: AI and CRISPR Genome Editing Webinar hosted by @Tech_Networks (September 29, virtual)
Excited to join this @SFBusinessTimes panel to share my career path from academia to industry. It’s an honor to represent @scribetx as one of #SFBTwomenwholead in the life sciences.
This Friday, Scribe’s Director of #MolecularEngineering @SarahSeq will join a ‘Rising Stars’ panel moderated by @rleuty_biotech for @SFBusinessTimes' 'Women Who Lead in Life Sciences' panel. For more about #SFBTwomenwholead, visit: bizjournals.com/sanfrancisco…
#CRISPRbyDesign #IWD2023
Sarah Denny retweeted
Announcing our latest partnership: We’re proud that @Sanofi selected our CRISPR by Design™ platform and genome editing XE technology to enable the development of novel natural killer cell therapies for cancer. fal.cn/3seJU
#CRISPR #CRISPRbyDesign #Oncology
Looking forward to discussing the profound impact of #ArtificialIntelligence on the drug development world, including in our work at @scribetx, with my fellow #WomenInBio. Thank you @SFWomenInBio and @Illumina for hosting! More at womeninbio.org/events/EventD…
#CRISPR #WomenInSTEM
Sarah Denny retweeted
Tomorrow is the last day to register for Wednesday’s @SFWomenInBio panel on the impact of artificial intelligence on drug discovery, featuring our Head of Molecular Engineering @SarahSeq! Grab your ticket now at womeninbio.org/events/EventD…
#WomenInBio @WomenInBio #CRISPR #AI
Sarah Denny retweeted
Primordium is now offering everyone the chance to sample our full-plasmid sequencing service for FREE - never use Sanger sequencing again! Please retweet this message and we'll DM you a coupon to sequence 5 ENTIRE PLASMIDS 100% FREE, no CC or PO needed. primordiumlabs.com 5/
Sarah Denny retweeted
Happy to share my last grad school paper published today @PNASNews pnas.org/content/pnas/118/33… in collaboration with @SarahSeq and @WJGreenleaf lab. Using high-throughput biochemistry to understand RNA 3D structure from the behavior of small recurring modular 3D building blocks.
Sarah Denny retweeted
1/ We’re excited to announce the completion of our $100M Series B financing to further develop our ”CRISPR by Design” platform and pipeline of #CRISPR-based in vivo genetic medicines that treat the underlying cause of disease. bwnews.pr/3w8uBzE
Excited to have you join Scribe, Jason!
Excited to be part of this team working to cure the underlying cause of genetic diseases! techcrunch.com/2020/10/06/sc…
Sarah Denny retweeted
1/ We are excited to take the wraps off Scribe Therapeutics - a molecular engineering company focused on building best-in-class in vivo therapies to permanently treat the underlying cause of disease. Read our launch press release: businesswire.com/news/home/2…









